AG0072SF

1263-89-4 | Paromomycin sulfate

AG0072SF

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	1263-89-4
Catalog Number	AG0072SF(AGN-PC-0PI9KV)
Chemical Name	Paromomycin sulfate
IUPAC Name	(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric acid
InChI	InChI=1S/C23H45N5O14.H2O4S/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22;1-5(2,3)4/h5-23,29-36H,1-4,24-28H2;(H2,1,2,3,4)/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1
InChI Key	LJRDOKAZOAKLDU-UDXJMMFXSA-N
MDL Number	MFCD00079278
Molecular Formula	C23H47N5O18S
Molecular Weight	713.7070
SMILES	N[C@@H](C[C@H]1N)[C@@]([C@@H]([C@H]1O)O[C@@](O[C@H](CO)[C@H]2O[C@@]([C@@H]([C@@H](O)[C@@H]3O)N)([H])O[C@H]3CN)([H])[C@@H]2O)([H])O[C@H]([C@@H]([C@@H](O)[C@@H]4O)N)O[C@@H]4CO.O=S(O)(O)=O
Synonyms	Aminosidine, beta-D-Glucopyranosyl-Isomer Paromomycin, Catenulin, Estomycin, Gabbromycin, Humatin, Hydroxymycin, Neomycin E, Paramomycin, Paromomycin, Paromomycin I, Paromomycin Phosphate, Paromomycin Sulfate, Paromomycin Sulfate (1:1), Paromomycin Sulfate (2:5), Paromomycin, beta D Glucopyranosyl Isomer, Paromomycin, beta-D-Glucopyranosyl-Isomer, Paromomycin sulfate, 1263-89-4, Paromomycin sulfate salt, Aminosidine sulfate, Paromomycin (sulfate), Aminosidin sulfate, Aminosidine sulphate, Gabbromicina, Humatin, Gabbroral, Humycin sulfate, Paromomycin sulphates, Aminoxidin, Farmiglucin, Farminosidin, Humagel, EINECS 215-031-7, MFCD00079278, Fi 5853, UNII-845NU6GJPS, Paromomycin sulfate [USP:JAN], paromomycin-sulfate, Humatin (TN), Paromomycine sulphate, ESTOMYCIN SULFATE, (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol; sulfuric acid, CRESTOMYCIN SULFATE, NCGC00166210-01, CAS-1263-89-4, SCHEMBL3355, 845NU6GJPS, DSSTox_CID_27806, DSSTox_RID_82574, DSSTox_GSID_47829, Paromomycin sulphate (1:1), MLS000028384, Paromomycin, sulfate (1:1), AC1L9B24, CHEBI:7935, 59-04-1 (base), Paromomycin sulfate (JAN/USP), CHEMBL2206196, DTXSID5047829, LJRDOKAZOAKLDU-UDXJMMFXSA-N, ZX-AFC000700, 7542-37-2 (base), D-Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-, sulfate (salt), HY-B0956, O-2,6-Diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-O-beta-D-ribofuranosyl-(1-5)-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxystreptamine sulfate (salt), C23H45N5O14.H2SO4, EINECS 230-575-5, Tox21_112349, s4183, AKOS015855755, AKOS016009094, CS-4433, KS-1378, MCULE-2666011467, AK110059, CPD000058551, H914, SAM002264633, SMR000058551, FT-0082539, ST24031510, D00868, 263P894, Q-201537, Z1551627167, hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric acid, Paromomycin sulfate, Antibiotic for Culture Media Use Only, (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside sulfate, (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol sulfate, (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(, (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol; sulfuric acid, 7205-49-4, D-Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1.fwdarw.3)-beta-D-ribofuranosyl-(1.fwdarw.5))-2-deoxy-, sulfate (salt), D-Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-1-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-O-beta-D-ribofuranosyl-(1-5))-2-deoxy-, sulfate (1:1) (salt), Sinosid, paromomycin, Paromomycin sulphate, Paromomycinsulfatesalt, Paromomycin sulfate [JAN], C23H45N5O14.xH2O4S, DRG-0188, CID441375, B1808, C23-H45-N5-O14.x-H2-O4-S, D-Streptamine, O-2-amino-2-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)-O-[O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.fwdarw.3)-.beta.-D-ribofuranosyl-(1.fwdarw.5)]-2-deoxy-, sulfate (salt), D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.fwdarw.3)-O-.beta.-D-ribofuranosyl-(1.fwdarw.5)-O-[2-amino-2-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)]-2-deoxy-, sulfate (salt), O-2,6-Diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-O-beta-D-ribofuranosyl-(1->5)-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxystreptamine sulfate (salt),

Complexity	952
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	19
Defined Bond Stereocenter Count	0
Exact Mass	713.264g/mol
Formal Charge	0
Heavy Atom Count	47
Hydrogen Bond Acceptor Count	23
Hydrogen Bond Donor Count	15
Isotope Atom Count	0
Molecular Weight	713.706g/mol
Monoisotopic Mass	713.264g/mol
Rotatable Bond Count	9
Topological Polar Surface Area	430A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P280-P305+P351+P338-P304+P340-P405-P501
UN Code

Certificate of Analysis

Lot Number